Search Results

There are 50161 results for: content related to: Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

  1. You have free access to this content
    Glypican-3 antibodies: A new therapeutic target for liver cancer

    FEBS Letters

    Volume 588, Issue 2, January 21, 2014, Pages: 377–382, Mingqian Feng and Mitchell Ho

    Version of Record online : 15 OCT 2013, DOI: 10.1016/j.febslet.2013.10.002

  2. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma

    Hepatology Research

    Volume 40, Issue 5, May 2010, Pages: 477–485, Eisuke Yasuda, Takashi Kumada, Hidenori Toyoda, Yuji Kaneoka, Atsuyuki Maeda, Seiji Okuda, Naoki Yoshimi and Osamu Kozawa

    Version of Record online : 30 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00624.x

    Corrected by:

    Erratum

    Vol. 41, Issue 1, 101, Version of Record online: 30 DEC 2010

  3. You have free access to this content
    Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma

    Hepatology

    Volume 56, Issue 4, October 2012, Pages: 1380–1390, Li Li, Ronghua Jin, Xiaoli Zhang, Fudong Lv, Lifeng Liu, Daojie Liu, Kai Liu, Ning Li and Dexi Chen

    Version of Record online : 4 OCT 2012, DOI: 10.1002/hep.25891

  4. You have full text access to this Open Access content
    Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and α-fetoprotein-producing gastric carcinomas

    Cancer Science

    Volume 100, Issue 4, April 2009, Pages: 626–632, Tetsuo Ushiku, 1 Hiroshi Uozaki, 1 Aya Shinozaki, 1 Satoshi Ota, 1 Keisuke Matsuzaka, 1 Sachiyo Nomura, 2 Michio Kaminishi, 3 Hiroyuki Aburatani, 4 Tatsuhiko Kodama and 4 Masashi Fukayama 1,5

    Version of Record online : 19 FEB 2009, DOI: 10.1111/j.1349-7006.2009.01108.x

  5. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

    Medicinal Research Reviews

    Fubo Zhou, Wenting Shang, Xiaoling Yu and Jie Tian

    Version of Record online : 16 JUN 2017, DOI: 10.1002/med.21455

  6. You have free access to this content
    High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy

    International Journal of Cancer

    Volume 137, Issue 7, 1 October 2015, Pages: 1643–1651, Yukihiro Haruyama, Kenji Yorita, Tetsuji Yamaguchi, Sachiko Kitajima, Jun Amano, Toshihiko Ohtomo, Akinobu Ohno, Kazuhiro Kondo and Hiroaki Kataoka

    Version of Record online : 6 APR 2015, DOI: 10.1002/ijc.29518

  7. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP

    Journal of Cellular Biochemistry

    Volume 114, Issue 3, March 2013, Pages: 625–631, Hui-Lai Miao, Zhi-Jian Pan, Chang-Jiang Lei, Ji-Yu Wen, Ming-Yi Li, Zhong-Kao Liu, Zhi-Dong Qiu, Man-Zhou Lin, Nian-Ping Chen and Ming Chen

    Version of Record online : 22 JAN 2013, DOI: 10.1002/jcb.24404

  8. You have free access to this content
    A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma

    Hepatology

    Volume 57, Issue 1, January 2013, Pages: 195–204, Marion Maurel, Sandra Jalvy, Yannick Ladeiro, Chantal Combe, Laetitia Vachet, Francis Sagliocco, Paulette Bioulac-Sage, Vincent Pitard, Hélène Jacquemin-Sablon, Jessica Zucman-Rossi, Benoît Laloo and Christophe F. Grosset

    Version of Record online : 7 JAN 2013, DOI: 10.1002/hep.25994

  9. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression

    Journal of Gastroenterology and Hepatology

    Volume 32, Issue 8, August 2017, Pages: 1503–1511, Ran Xue, Jiliang Feng, Qinghua Meng, Fudong Lv, Yueke Zhu, Hongwei Yu, Shijie Zhang, Chenzhao Song, Lin Sun, Zhujun Yue, Shuai Feng, Ruiwen Che, Qian Xiang and Xiaodan Jing

    Version of Record online : 28 JUL 2017, DOI: 10.1111/jgh.13736

  10. You have free access to this content
    The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2

    Hepatology

    Volume 46, Issue 5, November 2007, Pages: 1541–1547, Lorri A. Morford, Christina Davis, Lin Jin, Aneta Dobierzewska, Martha L. Peterson and Brett T. Spear

    Version of Record online : 1 AUG 2007, DOI: 10.1002/hep.21825

  11. You have free access to this content
    Glypican-3 immunocytochemistry in liver fine-needle aspirates

    Cancer Cytopathology

    Volume 111, Issue 5, 25 October 2007, Pages: 316–322, Dina Kandil, Gladwyn Leiman, Mark Allegretta, Winifred Trotman, Liron Pantanowitz, Robert Goulart and Mark Evans

    Version of Record online : 30 AUG 2007, DOI: 10.1002/cncr.22954

  12. You have free access to this content
    MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3

    FEBS Letters

    Volume 586, Issue 6, March 23, 2012, Pages: 884–891, Na Huang, Jing Lin, Jian Ruan, Ning Su, Ruzhai Qing, Feiye Liu, Benfu He, Chengwei Lv, Dayong Zheng and Rongcheng Luo

    Version of Record online : 20 FEB 2012, DOI: 10.1016/j.febslet.2012.02.017

  13. You have free access to this content
    Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3

    The FEBS Journal

    Volume 283, Issue 20, October 2016, Pages: 3739–3754, Xiao-ting Zhu, Ji-hang Yuan, Teng-teng Zhu, Yang-yang Li and Xiao-yang Cheng

    Version of Record online : 21 SEP 2016, DOI: 10.1111/febs.13839

  14. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  15. The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma

    Liver International

    Volume 29, Issue 7, August 2009, Pages: 1056–1064, Hirotake Takai, Atsuhiko Kato, Chie Kato, Takeshi Watanabe, Koichi Matsubara, Masami Suzuki and Hiroaki Kataoka

    Version of Record online : 8 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01968.x

  16. You have free access to this content
    Poster Session 4: Experimental Hepatocarcinogenesis; Hepatitis B: Treatment

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1151A–1181A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28238

  17. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns

    Histopathology

    Volume 56, Issue 6, May 2010, Pages: 750–757, Debra L Zynger, John C McCallum, Chunyan Luan, Pauline M Chou and Ximing J Yang

    Version of Record online : 28 APR 2010, DOI: 10.1111/j.1365-2559.2010.03553.x

  18. You have full text access to this OnlineOpen article
    Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3

    Clinical Case Reports

    Volume 3, Issue 6, June 2015, Pages: 444–447, Issei Kawashima, Yuri Kawashima, Yasuo Matsuoka, Kiyotaka Fujise, Hideki Sakai, Mari Takahashi, Toshiaki Yoshikawa, Tetsuya Nakatsura, Takeshi Ishihara and Tadao Ohno

    Version of Record online : 17 APR 2015, DOI: 10.1002/ccr3.279

  19. You have free access to this content
    Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo

    International Journal of Cancer

    Volume 126, Issue 6, 15 March 2010, Pages: 1291–1301, Sandra I. Zittermann, Mariana I. Capurro, Wen Shi and Jorge Filmus

    Version of Record online : 8 OCT 2009, DOI: 10.1002/ijc.24941

  20. You have free access to this content
    Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy

    Hepatology

    Volume 60, Issue 2, August 2014, Pages: 576–587, Wei Gao, Heungnam Kim, Mingqian Feng, Yen Phung, Charles P. Xavier, Jeffrey S. Rubin and Mitchell Ho

    Version of Record online : 18 JUN 2014, DOI: 10.1002/hep.26996